MAGGIO, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 3.803
EU - Europa 2.350
AS - Asia 942
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 6
SA - Sud America 4
AF - Africa 1
Totale 7.116
Nazione #
US - Stati Uniti d'America 3.793
IE - Irlanda 798
CN - Cina 511
TR - Turchia 337
SE - Svezia 312
DE - Germania 309
IT - Italia 242
UA - Ucraina 208
GB - Regno Unito 201
FI - Finlandia 101
FR - Francia 90
SG - Singapore 51
CZ - Repubblica Ceca 25
BE - Belgio 23
IN - India 20
EU - Europa 8
VN - Vietnam 7
CA - Canada 6
CH - Svizzera 6
IL - Israele 6
NL - Olanda 6
RU - Federazione Russa 5
RO - Romania 4
AU - Australia 3
BG - Bulgaria 3
KR - Corea 3
NZ - Nuova Zelanda 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BR - Brasile 2
IR - Iran 2
MD - Moldavia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MK - Macedonia 1
MX - Messico 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 7.116
Città #
Chandler 948
Jacksonville 839
Dublin 798
Nanjing 186
Boardman 163
Izmir 159
San Mateo 157
Wilmington 122
Lawrence 118
Princeton 118
Ashburn 109
New York 107
Ann Arbor 106
L'aquila 69
Bremen 58
Des Moines 48
Nanchang 44
Beijing 40
Woodbridge 39
Seattle 37
Singapore 36
Milan 34
Shenyang 31
Hebei 29
Verona 29
Munich 27
Brussels 23
Brno 22
Mountain View 22
Norwalk 20
Cachan 18
Jiaxing 18
Jinan 18
Los Angeles 17
Tianjin 17
Changsha 15
Kunming 14
Ningbo 13
Fremont 12
Helsinki 11
L’Aquila 11
Cambridge 9
Changchun 9
Hangzhou 8
Taizhou 8
Lanzhou 7
Zhengzhou 7
Auburn Hills 6
Dallas 6
Dearborn 6
Dong Ket 6
Edinburgh 6
Teramo 6
Washington 6
Falls Church 5
Hanover 5
Pescara 5
Shanghai 5
Chieti 4
Cupertino 4
Düsseldorf 4
Haikou 4
Philadelphia 4
Pune 4
Venezia 4
Adliswil 3
Berlin 3
Houston 3
Sofia 3
Tel Aviv 3
Warsaw 3
Agnone 2
Andover 2
Bolton 2
Braga 2
Cepagatti 2
Chicago 2
Chisinau 2
Christchurch 2
Florence 2
Fuzhou 2
Genova 2
Lugano 2
Mentana 2
Padova 2
Paris 2
Phoenix 2
Prague 2
Redmond 2
Redwood City 2
Rome 2
Saint Paul 2
Santa Clara 2
Stockholm 2
Tappahannock 2
Vancouver 2
Vittuone 2
Würzburg 2
Alanno 1
Amsterdam 1
Totale 4.914
Nome #
An internal ribosome entry site (IRES), present within the third cytoplasmic loop, drives the expression of the Carboxyl-terminal domain of the human muscarinic M2 receptor 132
Fluorescent light induces neurodegeneration in the rodent nigrostriatal system but near infrared LED light does not. 131
Nitric oxide synthase inhibition reverts muscarinic receptor down-regulation induced by pilocarpine- and kainic acid-evoked seizures in rat fronto-parietal cortex 94
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 89
The atypical antipsychotic clozapine selectively inhibits interleukin 8 (IL-8)-induced neutrophil chemotaxis. 87
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 85
The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT) 84
Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3receptors 83
Dextromethorphan prevents the diethyldithiocarbamate enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice 82
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson’s disease epidemiology 81
The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptors. 78
Reconstituition of functional muscarinic receptors by coexpression of amino and carboxyl terminal receptor fragments 76
G protein-coupled receptor oligomerization provides the framework for signal discrimination 75
D2/D3 dopamine receptor heterodimers exhibit unique functional properties 75
Dysbindin-1 modifies signaling and cellular localization of recombinant, human D3 and D2 receptors 75
Experimental strategies for studying G protein-coupled receptor homo- and heteromerization with radioligand binding and signal transduction methods. 73
Eyes as gateways for environmental light to the substantia nigra: relevance in Parkinson's disease 72
Apomorphine has a potent antiproliferative effect on Chinese hamster ovary cells. 72
Reconstitution of functional dopamine D2s receptors by co-expression of amino- and carboxyl-terminal receptor fragments 72
Variants of G protein-coupled receptors: a reappraisal of their role in receptor regulation 72
Pergolide binds tightly to dopamine D2 short receptors and induces receptor sequestration 71
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. 71
Dopamine D2receptors dimers: How can we pharmacologically target them? 70
High affinity binding sites for 1-methyl-4-phenyl-pyridinium ion (MPP+) are present in mouse brain. 70
Neurotoxic and Neuroprotective Role of Exosomes in Parkinson's Disease 70
Dichlorodiphenyltrichloroethane, an old pesticide with a new mechanism of toxicity 69
Functional role of the third cytoplasmic loop in muscarinic receptor dimerization 68
Apomorphine, dopamine and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate I 67
[3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: pharmacological and biological characterization 67
Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA). 67
A quantitative analysis of antidepressant and antipsychotic prescriptions following an earthquake in Italy 67
THE THYROID DISRUPTOR 1,1,1-TRICHLORO-2,2-BIS(P-CHLOROPHENYL)ETHANE (DDT) PREVENTS INTERNALIZATION OF THE TSH RECEPTOR 66
Binding profile of the selective muscarinic receptor antagonist tripitramine 66
Seizure evoked from area tempestas are subject to control by GABA and glutamate receptor in substantia nigra. 66
Revealing GPCR oligomerization at the single-molecule level through a nanoscopic lens: methods, dynamics and biological function 66
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences 66
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 66
L’educazione al corretto uso dei farmaci nell’ambito della promozione della salute 65
Historical Perspectives: From Monomers to Dimers and Beyond, an Exciting Journey in the World of G Protein-Coupled Receptors 65
Lack of proconvulsant action of GABA depletion in substantia nigra in several seizure models 64
Pharmacological evidence of muscarinic receptor heterodimerization. 64
Neurotrasmissione Colinergica Farmaci Colinomimetici ed Anticolinergici. Trattato di Farmacologia (II Edizione) 64
Paired activation of the two components within muscarinic M3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane 63
Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular “cross-talk” between G-protein-linked receptors 63
Blockade of GABA receptor in superior colliculus protects against focally-evoked limbic motor seizures 63
Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D(1)/D(2)/D(3) receptors vs D(2)/D(3) receptors only: parallel observations from co-transfected human and native cerebral receptors. 63
The insecticide 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane (DDT) alters the membrane raft location of the TSH receptor stably expressed in Chinese hamster ovary cells. 63
The First Negative Allosteric Modulator for Dopamine D2and D3Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs 63
Motor expression of kainic acid seizures is attenuated by dopamine depletion in mice 62
Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studies by mutational analysis of the m3 muscarinic receptor 62
Affinity profiles at five cloned human muscarinic receptors (m1-m5) of a new series of antimuscarinic drugs. 62
Sodium nitroprusside induces internalization of muscarinic receptors stbly expressed in CHO cell line 61
Deoxamuscaroneoxime derivatives as useful muscarinic agonists to explore the muscarinic subsite. Demox, a modulator of orthostetic and allosteric sites at cardiac muscarinic M2 receptors 61
Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor 61
Valutazione dell’espressione di geni inducibili in un modello sperimentale di epilessia parziale complessa. 61
Are olfactory receptors really olfactive? 61
Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation 61
Role of excitatory amino-acids in diethyldithiocarbamate-induced cell death in mesencephalic cultures 61
Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells 61
Heterodimerization of G-protein-coupled receptor reveals an unexpected level of pharmacological diversity. 60
Apomorphine continuous stimulation in Parkinson’s Disease: receptor desensitization as a possible mechanism of reduced motor response. 60
Expression of c-fos mRNA following seizures evoked from an epileptogenic site in the deep prepiriform cortex: Regional distribution in brain as shown by in situ hybridization. 59
Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors 59
Dopamine D(2)-D(3) receptor heteromers: pharmacological properties and therapeutic significance 58
L-Deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion 58
Dichlorodiphenyltrichloroethane (DDT) induced extracellular vesicle formation: a potential role in organochlorine increased risk of Parkinson's disease 58
Novel dimensions of D3 receptor function: Focus on heterodimerisation, transactivation and allosteric modulation 58
Neurotrasmissione colinergica e farmaci colinomimetici ed anticolinerici. 58
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 56
Inhibition of nitric oxide synthase dramatically affects seizures induced by kainic acid and pilocarpine in rats. 56
The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor 55
Regional changes in immediate early gene expression following focally-evoked limbic motor seizures. 55
Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance. 55
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 55
Temporal and spatial pattern of expression of c-fos, zif/268, c-jun and jun-B mRnas in rat brain following seizures evoked focally from the deep prepiriform cortex. 54
Excitatory amino acids and MPTP toxicity. 54
Un’analisi delle prescrizioni di farmaci antidepressivi e antipsicotici nell’ASL de L’Aquila nei 6 mesi dopo il sisma. 54
G protein-linked receptors: pharmacological evidence for the formation of heterodimers 54
Receptor Oligomerization as a Process Modulating Cellular Semiotics. 54
Receptor cross-talk: haloperidol treatment enhances A2A adenosine receptor functioning in a transfected cell model. 53
Stereoselective inhibition of muscarinic receptor subtypes by the stereoisomers related to rociverine 53
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 53
Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. 53
Selective stimulation of kainate but not quisqualate or NMDA receptors in substantia nigra evokes limbic motor seizures 52
Semiotic Selection of Mutated or Misfolded Receptor Proteins. 52
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors 51
Mapping pathways of focally-evoked seizures using early response gene expression. 51
Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in central Italy 51
Molecular and cellular events regulating dopamine neuron survival. 51
Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole 50
Functional rescue of the inactive splice variant of the dopamine D3 receptor D3nf 50
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 50
A New Threat to Dopamine Neurons: The Downside of Artificial Light 50
Role of brainstem Structures in seizures initiated from the deep prepiriformcortex of rats. 49
Role of conserved threonine residues in acetylcholine binding and muscarinic receptor activation 49
Parkinson's disease and light: The bright and the Dark sides 49
Correlation with 3H-MPP+ binding sites by debrisoquine and some analogues in mouse brain. 49
Polyamines may modulate both G-protein-coupled receptors and G protein. 48
An unusual form of the association binding kinetics of N-[3H]-methylscopolamine to the split muscarinic M2trunk/M2tail receptor 48
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 48
Totale 6.405
Categoria #
all - tutte 29.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020672 0 6 108 4 6 127 158 3 110 30 12 108
2020/2021909 8 107 9 108 108 30 124 13 112 38 212 40
2021/2022778 33 69 134 39 41 9 14 46 62 10 47 274
2022/20232.573 175 184 55 292 248 280 0 172 1.040 14 77 36
2023/2024592 79 37 33 87 36 160 19 50 1 16 39 35
2024/202579 56 23 0 0 0 0 0 0 0 0 0 0
Totale 7.219